Anti cancer virotherapy well tolerated in first human administration, research finds
Researchers at Newcastle University tested a cancer virotherapy on two patients with advanced melanoma, finding no systemic toxic effects. The administration of CVA21 virus directly into cancerous tumors was well-tolerated and showed promise in controlling the spread of melanoma.